Newsfiscal.ai
Cognition Therapeutics Receives Nasdaq Deficiency Notice Regarding Bid Price
· Published
Article summary
Cognition Therapeutics disclosed that it received a notification from Nasdaq indicating that its closing bid price fell below the $1.00 minimum requirement for continued listing.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…